MedTrace Logo

The Effect of Tranexamic Acid for Total Hip Arthroplasty

NCT02094066 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-03-26

No results posted yet for this study

Summary

The aim of this study is to investigate the effects of tranexamic acid on hemorrhage, blood transfusion, fibrin degradation products and kidney functions for total hip arthroplasty.

Conditions

Interventions

DRUG

tranexamic acid

preoperative ıv 50 mg/kg tranexamic acid infusion at 45 minutes

DRUG

serum physiologic

preoperative 100 cc ıv serum physiologic

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • seher orbay yasli, resident · Erciyes university medicine faculty

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-06-30
Completion
2014-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094066 on ClinicalTrials.gov